2415 — MedSci Healthcare Holdings Income Statement
0.000.00%
- HK$985.95m
- -HK$228.41m
- CNY349.19m
- 72
- 65
- 15
- 49
Annual income statement for MedSci Healthcare Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 216 | 298 | 349 | 349 |
Cost of Revenue | ||||
Gross Profit | 117 | 190 | 206 | 217 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 182 | 445 | 445 | 288 |
Operating Profit | 33.6 | -147 | -95.9 | 60.7 |
Total Net Non Operating Interest Income / Expense | ||||
Net Income Before Taxes | 33.2 | -147 | -96.3 | 60.5 |
Provision for Income Taxes | ||||
Net Income After Taxes | 28.9 | -151 | -99.9 | 55 |
Net Income Before Extraordinary Items | ||||
Net Income | 28.9 | -151 | -99.9 | 55 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 28.9 | -151 | -99.9 | 55 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 3.03 | -0.248 | -0.126 | 0.129 |